Bowhead Specialty Holdings Inc.
Bowhead Specialty Holdings Inc. (BOW) Financial Performance & Income Statement Overview
Analyze Bowhead Specialty Holdings Inc. (BOW) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Bowhead Specialty Holdings Inc. (BOW) Income Statement & Financial Overview
Analyze Bowhead Specialty Holdings Inc.’s BOW earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $122.72M | $119.39M | $116.76M | $98.87M |
| Cost of Revenue | $247000.00 | $487000.00 | $487000.00 | $0.00 |
| Gross Profit | -$247000.00 | $119.33M | $116.27M | $98.87M |
| Gross Profit Ratio | -$0.002 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $21.36M |
| Operating Expenses | -$14.72M | -$18.50M | $116.72M | $22.82M |
| Total Costs & Expenses | -$14.47M | $101.08M | $116.72M | -$89.42M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $247000.00 | $248000.00 | $252000.00 | $224000.00 |
| Depreciation & Amortization | $401000.00 | $1.10M | $1.05M | $960000.00 |
| EBITDA | $14.87M | $19.35M | $17.12M | $8.59M |
| EBITDA Ratio | $0.12 | $0.16 | $0.15 | $0.09 |
| Operating Income | $14.47M | $18.25M | $17.39M | $10.94M |
| Operating Income Ratio | $0.12 | $0.15 | $0.15 | $0.11 |
| Other Income/Expenses (Net) | $0.00 | $0.00 | -$1.57M | -$70.13M |
| Income Before Tax | $14.47M | $18.25M | $15.82M | $7.41M |
| Income Before Tax Ratio | $0.12 | $0.15 | $0.14 | $0.07 |
| Income Tax Expense | $3.04M | $4.64M | $3.73M | $1.88M |
| Net Income | $11.43M | $13.61M | $12.09M | $5.53M |
| Net Income Ratio | $0.09 | $0.11 | $0.10 | $0.06 |
| EPS | $0.35 | $0.42 | $0.37 | $0.20 |
| Diluted EPS | $0.34 | $0.41 | $0.36 | $0.20 |
| Weighted Avg Shares Outstanding | $32.66M | $32.66M | $32.66M | $27.65M |
| Weighted Avg Shares Outstanding (Diluted) | $33.71M | $33.57M | $33.26M | $27.77M |
The company's financials show resilient growth, with revenue advancing from $98.87M in Q2 2024 to $122.72M in Q1 2025. Gross profit remained healthy with margins at -0% in Q1 2025 compared to 100% in Q2 2024. Operating income hit $14.47M last quarter, sustaining a consistent 12% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $14.87M. Net income dropped to $11.43M, while earnings per share reached $0.35. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan